These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1679780)

  • 1. Designing future vaccines.
    Brown F
    J Hosp Infect; 1991 Jun; 18 Suppl A():164-9. PubMed ID: 1679780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of vaccine vectors.
    Dorner F
    Dev Biol Stand; 1995; 84():23-32. PubMed ID: 7796959
    [No Abstract]   [Full Text] [Related]  

  • 3. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of plant-made vaccines for veterinary purposes.
    Ling HY; Pelosi A; Walmsley AM
    Expert Rev Vaccines; 2010 Aug; 9(8):971-82. PubMed ID: 20673018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches for genetic purity testing of live recombinant viral vaccines using a human adenovirus:rabies model.
    Lutze-Wallace C; Sapp T; Nadin-Davis SA; Wandeler A
    Can J Vet Res; 1992 Oct; 56(4):360-4. PubMed ID: 1477804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to vaccination: polymorphic vaccines for RNA viruses.
    Cohen JI
    Med Hypotheses; 2000 Oct; 55(4):353-5. PubMed ID: 11000067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined vaccines including 1 or several anti-foot-and-mouth valences].
    Fontaine J; Favre H; Valette L; Précausta P; Roulet C; Brun A; Terré J
    Dev Biol Stand; 1976; 35():395-407. PubMed ID: 198308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthetic peptide vaccines].
    Moĭsa AA; Kolesanova EF
    Biomed Khim; 2011; 57(1):14-30. PubMed ID: 21516776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
    Yusibov V; Hooper DC; Spitsin SV; Fleysh N; Kean RB; Mikheeva T; Deka D; Karasev A; Cox S; Randall J; Koprowski H
    Vaccine; 2002 Aug; 20(25-26):3155-64. PubMed ID: 12163267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baculovirus expression vector system for production of viral vaccines.
    Vlak JM; Keus RJ
    Adv Biotechnol Processes; 1990; 14():91-128. PubMed ID: 2222839
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis of hepatitis B virus core antigen (HBcAg) particles by recombinant vaccinia virus].
    Loparev VN; Araslanov RR; Mitina IV; Antonova TP; Ianova NN; Iashina TL; Chernos VI
    Mol Gen Mikrobiol Virusol; 1990 Oct; (10):18-22. PubMed ID: 1702184
    [No Abstract]   [Full Text] [Related]  

  • 14. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From virus to vaccine: developments using the simple eukaryote, Dictyostelium discoideum.
    Emslie KR; Slade MB; Williams KL
    Trends Microbiol; 1995 Dec; 3(12):476-9. PubMed ID: 8800841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary.
    Jamal SM; Shah SI; Ali Q; Mehmood A; Afzal M; Afzal M; Dekker A
    Transbound Emerg Dis; 2014 Dec; 61(6):483-9. PubMed ID: 23305464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness.
    Stephenne J
    Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to vaccination against foot-and-mouth disease.
    Brown F
    Vaccine; 1992; 10(14):1022-6. PubMed ID: 1335197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of animal rabies by an attenuated monovalent or mixed vaccine].
    Soulebot JP; Précausta P; Brun A; Chappuis G; Terré J; Favre H; Petermann HG
    Dev Biol Stand; 1978; 41():389-99. PubMed ID: 753667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of rabies with a vaccine produced from recombinant DNA].
    Boll Chim Farm; 1991; 130(7):285-6. PubMed ID: 1756014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.